Wenyi Wang

787 total citations
24 papers, 616 citations indexed

About

Wenyi Wang is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Wenyi Wang has authored 24 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Neurology. Recurrent topics in Wenyi Wang's work include Metabolomics and Mass Spectrometry Studies (3 papers), MicroRNA in disease regulation (3 papers) and Cell death mechanisms and regulation (3 papers). Wenyi Wang is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (3 papers), MicroRNA in disease regulation (3 papers) and Cell death mechanisms and regulation (3 papers). Wenyi Wang collaborates with scholars based in China, Taiwan and United States. Wenyi Wang's co-authors include Ai-Lin Bian, Xin-Zi Zhou, Ying Guo, Yue Ma, Yiran Zhang, Xiaofei Wang, Wen‐Ying Chen, Cheng-Yi Chang, Meiling Yan and Su‐Lan Liao and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Environmental Health Perspectives.

In The Last Decade

Wenyi Wang

23 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyi Wang China 15 311 153 115 59 51 24 616
Shanker Datt Joshi India 9 300 1.0× 185 1.2× 90 0.8× 29 0.5× 51 1.0× 11 695
Rokibul Islam Bangladesh 11 278 0.9× 70 0.5× 94 0.8× 38 0.6× 97 1.9× 21 577
Hui‐Zhi Long China 11 499 1.6× 130 0.8× 252 2.2× 26 0.4× 74 1.5× 16 904
Shaowu Cheng China 19 412 1.3× 187 1.2× 137 1.2× 30 0.5× 66 1.3× 41 901
Huafeng Pan China 14 313 1.0× 87 0.6× 94 0.8× 19 0.3× 46 0.9× 47 657
Hu Tian China 14 295 0.9× 95 0.6× 138 1.2× 28 0.5× 46 0.9× 41 655
Zu‐Guo Zheng China 14 364 1.2× 86 0.6× 71 0.6× 45 0.8× 123 2.4× 34 668
Yousheng Mo China 15 324 1.0× 139 0.9× 133 1.2× 19 0.3× 53 1.0× 24 775
Dingzhu Shen China 16 302 1.0× 123 0.8× 112 1.0× 33 0.6× 122 2.4× 32 722
Silvia Friedrichs Germany 15 254 0.8× 86 0.6× 45 0.4× 34 0.6× 58 1.1× 26 643

Countries citing papers authored by Wenyi Wang

Since Specialization
Citations

This map shows the geographic impact of Wenyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Wang more than expected).

Fields of papers citing papers by Wenyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Wang. The network helps show where Wenyi Wang may publish in the future.

Co-authorship network of co-authors of Wenyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyi Wang. A scholar is included among the top collaborators of Wenyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyi Wang. Wenyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chih-Cheng, Chung‐Yuh Tzeng, Cheng-Yi Chang, et al.. (2023). NMDA receptor inhibitor MK801 alleviated pro-inflammatory polarization of BV-2 microglia cells. European Journal of Pharmacology. 955. 175927–175927. 12 indexed citations
2.
Wang, Yayu, Shih‐Yi Lin, Cheng-Yi Chang, et al.. (2023). α7 nicotinic acetylcholine receptor agonist improved brain injury and impaired glucose metabolism in a rat model of ischemic stroke. Metabolic Brain Disease. 38(4). 1249–1259. 6 indexed citations
4.
5.
Wang, Wenyi, Ko Willems van Dijk, Carolien A. Wijsman, et al.. (2021). Differential insulin sensitivity of NMR-based metabolomic measures in a two-step hyperinsulinemic euglycemic clamp study. Metabolomics. 17(6). 57–57.
6.
Bian, Ai-Lin, Yue Ma, Xin-Zi Zhou, et al.. (2020). Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskeletal Disorders. 21(1). 214–214. 147 indexed citations
7.
Wang, Yayu, Cheng-Yi Chang, Shih‐Yi Lin, et al.. (2020). Quercetin protects against cerebral ischemia/reperfusion and oxygen glucose deprivation/reoxygenation neurotoxicity. The Journal of Nutritional Biochemistry. 83. 108436–108436. 66 indexed citations
8.
Jiang, Yuliang, Tao Wen, Rui Yan, et al.. (2020). O‐glycans on death receptors in cells modulate their sensitivity to TRAIL‐induced apoptosis through affecting on their stability and oligomerization. The FASEB Journal. 34(9). 11786–11801. 25 indexed citations
9.
Chang, Cheng-Yi, Jian‐Ri Li, Chih-Cheng Wu, et al.. (2020). Endoplasmic Reticulum Stress Contributes to Indomethacin-Induced Glioma Apoptosis. International Journal of Molecular Sciences. 21(2). 557–557. 21 indexed citations
10.
Banik, Avijit, Shabber Mohammed, Asheebo Rojas, et al.. (2020). Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models. Journal of Medicinal Chemistry. 63(3). 1032–1050. 28 indexed citations
11.
Wang, Wenyi, et al.. (2019). Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease. Lipids in Health and Disease. 18(1). 22–22. 30 indexed citations
12.
14.
Chang, Cheng-Yi, Jian‐Ri Li, Chih-Cheng Wu, et al.. (2018). Indomethacin induced glioma apoptosis involving ceramide signals. Experimental Cell Research. 365(1). 66–77. 15 indexed citations
15.
Wang, Wenyi, et al.. (2018). MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus. Biochemical and Biophysical Research Communications. 500(3). 577–582. 26 indexed citations
16.
Li, Jianchao, Yifei Liu, Mingming Xu, et al.. (2017). Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer. Pathology & Oncology Research. 25(1). 115–121. 12 indexed citations
17.
Wang, Wenyi, et al.. (2016). Relationship between bone mineral density and serum adiponectin in elderly men. 18(8). 1190–1193. 1 indexed citations
18.
Zou, Zhengzhi, Xiaoyong Luo, Peipei Nie, et al.. (2016). Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors. Biochemical and Biophysical Research Communications. 478(1). 227–233. 19 indexed citations
19.
Kim, Marlene T., Ruili Huang, Alexander Sedykh, et al.. (2015). Mechanism Profiling of Hepatotoxicity Caused by Oxidative Stress Using Antioxidant Response Element Reporter Gene Assay Models and Big Data. Environmental Health Perspectives. 124(5). 634–641. 55 indexed citations
20.
Liao, Su‐Lan, Yen‐Chuan Ou, Wen‐Ying Chen, et al.. (2013). Diethylmaleate and iodoacetate in combination caused profound cell death in astrocytes. Journal of Neurochemistry. 127(2). 271–282. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026